Injuries of Pelvis is part of the Spine & Pelvis section of Orthopaedics. Practise 5 exam-style MCQs for NEET PG, FMGE, INI-CET and NEET SS, each with the correct answer and a detailed explanation.
Injuries of Pelvis MCQs include giant cell tumour management in difficult pelvic and sacral sites, where denosumab offers a medical option, in a brief high-yield NEET PG set for FMGE, INI-CET and NEET SS.
Sample Injuries of Pelvis MCQs with answers
Sample MCQ #1
Which of the following drugs can be used in the treatment of GCT of pelvis?
AAlendronate
BZolindronic acid
CDenosumab
DTocilizumab
Show Answer & Explanation ▾
✓ Correct Answer: C. Denosumab
Denosumab can be used in the treatment of GCT, especially in those tumors that arise in difficult to access areas such as the pelvis and the sacrum. Denosumab is a monoclonal antibody that blocks RANK ligands. The tumor cells in GCT acts via the RANK ligands to stimulate the osteoclasts. And its this activated osteoclasts that destroy the bone in GCT. Therefore, Denosumab can stop activation of osteoclasts, thereby causing shrinkage of the tumor. Reference: Miler's 8th Edition of Review of Orthopaedics, page no. 1895
What you can practise in Injuries of Pelvis
5 Injuries of Pelvis MCQs on Injuries, Pelvis, Spine & Pelvis — each with detailed explanations
Previous-year question practice across NEET PG, FMGE, INI-CET and NEET SS
Progress and performance tracking to measure retention
Injuries of Pelvis MCQs include giant cell tumour management in difficult pelvic and sacral sites, where denosumab offers a medical option, in a brief high-yield NEET PG set for FMGE, INI-CET and NEET SS.
How many Injuries of Pelvis questions are there, and which exams do they cover?
MedLadder includes 5 curated MCQs for Injuries of Pelvis under Orthopaedics (Spine & Pelvis), covering NEET PG, FMGE, INI-CET and NEET SS preparation.
